• Mirtallo J, Canada T, Johnson D, Kumpf V, Petersen C, Sacks G, Seres D, Guenter P, Task Force for the Revision of Safe Practices for Parenteral Nutrition. Labeling parenteral nutrition formulations. In: Safe practices for parenteral nutrition. JPEN J Parenter Enteral Nutr 2004 Nov-Dec;28(6):S48-52. [3 references]

This is the current release of the guideline.

1. The labels for parental nutrition (PN) formulations shall be standardized and include:
   • The amount per day is the only column required on the label for the base formula, electrolyte additives, micronutrients and medications. This supports the use of the 24-hour nutrient infusion system.
   • Using the quantity per liter option in parenthesis supports those programs that continue to admix PN in 1 liter volumes.
   • The dosing weight is required on the label.
2. Auxiliary labels or information may be used.
3. Patient transfer between healthcare environments requires pharmacist-to-pharmacist communication and documentation to insure the accurate transfer of the PN prescription.
4. The PN label is compared with the PN order and for beyond-use date before administration.

None provided

The recommendations are supported by a review of the literature as well as results from the 2003 American Society for Parenteral and Enteral Nutrition Survey.

• Mirtallo J, Canada T, Johnson D, Kumpf V, Petersen C, Sacks G, Seres D, Guenter P, Task Force for the Revision of Safe Practices for Parenteral Nutrition. Labeling parenteral nutrition formulations. In: Safe practices for parenteral nutrition. JPEN J Parenter Enteral Nutr 2004 Nov-Dec;28(6):S48-52. [3 references]

Not applicable: The guideline was not adapted from another source.

2004 Dec

American Society for Parenteral and Enteral Nutrition - Professional Association

American Society for Parenteral and Enteral Nutrition

Task Force for the Revision of Safe Practices for Parenteral Nutrition

Task Force Members: Jay Mirtallo, MS, RPh, BCNSP, Chair; Todd Canada, PharmD, BCNSP; Deborah Johnson, MS, RN; Vanessa Kumpf, PharmD, BCNSP; Craig Petersen, RD, CNSD; Gordon Sacks, PharmD, BCNSP; David Seres, MD, CNSP; Peggi Guenter, PhD, RN, CNSN

Not stated

This is the current release of the guideline.

This NGC summary was completed by ECRI Institute on July 8, 2008. The information was verified by the guideline developer on July 30, 2008.

This NGC summary is based on the original guideline, which is subject to the guideline developer's copyright restrictions. Reprint request/permissions should be sent to: Permissions Department, ASPEN; 8630 Fenton St. #412; Silver Spring, MD 20910; Fax: 301-587-2365.